Transcription factor AP-2β: A negative regulator of IRS-1 gene expression

Biochemical and Biophysical Research Communications

Volumn 392, Issue 4, 2010, Pages 526-532

  Meng, Xiangning ^a,b   Kondo, Motoyuki ^b   Morino, Katsutaro ^b   Fuke, Tomoya ^b   Obata, Toshiyuki ^b   Yoshizaki, Takeshi ^b   Ugi, Satoshi ^b   Nishio, Yoshihiko ^b   Maeda, Shiro ^c   Araki, Eiichi ^d   Kashiwagi, Atsunori ^b   Maegawa, Hiroshi ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

Author keywords

3T3 L1 adipocytes; AP 2 ; Insulin resistance; IRS 1; Type 2 diabetes

Indexed keywords

ADIPOCYTOKINE; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2BETA; UNCLASSIFIED DRUG;

ADENOVIRUS; ADIPOCYTE; ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRAIN 3T3; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INSULIN RESISTANCE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; VIRUS RECOMBINANT;

3T3-L1 CELLS; ANIMALS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MICE; MICE, INBRED STRAINS; MUTATION; NUCLEIC ACID CONFORMATION; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-2;

EID: 76749168404     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.01.056     Document Type: Article

References (33)

1. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787
2. Kahn B.B. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell 92 (1998) 593-596
3. Saltiel A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104 (2001) 517-529
4. Carvalho E., Jansson P.A., Nagaev I., et al. Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport. FASEB J. 15 (2001) 1101-1103
5. Rondinone C.M., Wang L.M., Lonnroth P., et al. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 94 (1997) 4171-4175
6. Anai M., Funaki M., Ogihara T., et al. Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes 47 (1998) 13-23
7. Kerouz N.J., Horsch D., Pons S., et al. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J. Clin. Invest. 100 (1997) 3164-3172
8. Veilleux A., Blouin K., Rheaume C., et al. Glucose transporter 4 and insulin receptor substrate-1 messenger RNA expression in omental and subcutaneous adipose tissue in women. Metabolism 58 (2009) 624-631
9. Aguirre V., Werner E.D., Giraud J., et al. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277 (2002) 1531-1537
10. Shah O.J., Wang Z., and Hunter T. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr. Biol. 14 (2004) 1650-1656
11. Rui L., Yuan M., Frantz D., et al. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277 (2002) 42394-42398
12. Gual P., Le Marchand-Brustel Y., and Tanti J.F. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87 (2005) 99-109
13. Maeda S., Tsukada S., Kanazawa A., et al. Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus. J. Hum. Genet. 50 (2005) 283-292
14. Lindgren C.M., Heid I.M., Randall J.C., et al. Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet. 5 (2009) e1000508
15. Nordquist N., Gokturk C., Comasco E., et al. The transcription factor TFAP2B is associated with insulin resistance and adiposity in healthy adolescents. Obesity (Silver Spring) 17 (2009) 1762-1767
16. Ikeda K., Maegawa H., Ugi S., et al. Transcription factor activating enhancer-binding protein-2beta. A negative regulator of adiponectin gene expression. J. Biol. Chem. 281 (2006) 31245-31253
17. Fuke T., Yoshizaki T., Kondo M., et al. Transcription factor AP-2β inhibits expression and secression of leptin, an insulin-sensitizing hormone, in 3T3-L1 adipocytes. Int. J. Obes. (Lond.) (2009) 10.1038/ijo.2009.295
18. Kondo M., Maegawa H., Obata T., et al. Transcription factor activating protein-2beta: a positive regulator of monocyte chemoattractant protein-1 gene expression. Endocrinology 150 (2009) 1654-1661
19. Ugi S., Nishio Y., Yamamoto H., et al. Relationship between the expression of transcriptional factor TFAP2B and that of adipokines in subcutaneous and omental adipose tissues. Obesity (Silver Spring) (2009) 10.1038/oby.2009.442
20. Tao Y., Maegawa H., Ugi S., et al. The transcription factor AP-2beta causes cell enlargement and insulin resistance in 3T3-L1 adipocytes. Endocrinology 147 (2006) 1685-1696
21. Ugi S., Imamura T., Maegawa H., et al. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol. Cell. Biol. 24 (2004) 8778-8789
22. Egawa K., Sharma P.M., Nakashima N., et al. Membrane-targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance. J. Biol. Chem. 274 (1999) 14306-14314
23. Araki E., Haag III B.L., Matsuda K., et al. Characterization and regulation of the mouse insulin receptor substrate gene promoter. Mol. Endocrinol. 9 (1995) 1367-1379
24. Hashimoto T., Nakamura T., Maegawa H., et al. Regulation of ATP-sensitive potassium channel subunit Kir6.2 expression in rat intestinal insulin-producing progenitor cells. J. Biol. Chem. 280 (2005) 1893-1900
25. Satoda M., Zhao F., Diaz G.A., et al. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat. Genet. 25 (2000) 42-46
26. Zhao F., Weismann C.G., Satoda M., et al. Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation. Am. J. Hum. Genet. 69 (2001) 695-703
27. Williams T., Admon A., Luscher B., et al. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev. 2 (1988) 1557-1569
28. Zhao F., Satoda M., Licht J.D., et al. Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J. Biol. Chem. 276 (2001) 40755-40760
29. Moser M., Imhof A., Pscherer A., et al. Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. Development 121 (1995) 2779-2788
30. Carvalho E., Jansson P.A., Axelsen M., et al. Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM. FASEB J. 13 (1999) 2173-2178
31. Serrano R., Villar M., Martinez C., et al. Differential gene expression of insulin receptor isoforms A and B and insulin receptor substrates 1, 2 and 3 in rat tissues: modulation by aging and differentiation in rat adipose tissue. J. Mol. Endocrinol. 34 (2005) 153-161
32. Rung J., Cauchi S., Albrechtsen A., et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat. Genet. 41 (2009) 1110-1115
33. Kovacs P., Hanson R.L., Lee Y.H., et al. The role of insulin receptor substrate-1 gene (IRS1) in type 2 diabetes in Pima Indians. Diabetes 52 (2003) 3005-3009